Pàgina inicial > Resultats de la cerca: Barac, A.
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 2 registres trobats en 0.02 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
1.
7 p, 264.1 KB European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment / Lee, G.A. (Division of Applied Technology for Clinical Care. Florence Nightingale Faculty of Nursing. Midwifery & Palliative Care. King's College London) ; Aktaa, S. (Department of Cardiology. Leeds Teaching Hospitals NHS Trust) ; Baker, E. (Division of Applied Technology for Clinical Care. Florence Nightingale Faculty of Nursing. Midwifery & Palliative Care. King's College London) ; Gale, C.P. (Department of Cardiology. Leeds Teaching Hospitals NHS Trust) ; Yaseen, I.F. (Scientific Council of Cardiology. Iraqi Board for Medical Specializations) ; Gulati, G. (Oslo University Hospital (Oslo, Noruega)) ; Asteggiano, R. (LARC (Laboratorio Analisi e Ricerca Clinica)) ; Szmit, S. (Institute of Hematology and Transfusion Medicine) ; Cohen-Solal, A. (Cardiology Department. Hôpitaux de Paris. Hôpital Lariboisière 2 Rue Ambroise Paré) ; Abdin, A. (Department of Internal Medicine III. Cardiology. Angiology. Intensive Care Medicine. Saarland University Medical Center) ; Jurczak, W. (MSC National Research Institute of Oncology) ; Garrido, Pilar (Jefe Servicio Oncología Médica. Hospital Ramón y Cajal) ; Sverdlov, A.L. (Newcastle Centre of Excellence in Cardio-Oncology. Calvary Mater Newcastle. Hunter Medical Research Institute. John Hunter Hospital. University of Newcastle) ; Tocchetti, C.G. (Cardio-Oncology Unit. Department of Translational Medical Sciences (DISMET). Center for Basic and Clinical Immunology Research (CISI). Interdepartmental Center for Clinical and Translational Research (CIRCET). Interdepartmental Hypertension Research Center (CIRIAPA). Federico II University) ; Barac, A. (Cardio-oncology Program. MedStar Heart and Vascular Institute) ; Parrini, I. (Department of Cardiology. Mauriziano Hospital) ; Zamorano, P. (Hospital Universitario Ramón y Cajal (Madrid)) ; Iakobishvili, Z. (Faculty of Health Sciences. Ben Gurion University of the Negev) ; Pudil, R. (University Hospital Hradec Králové. Sokolská) ; Badimon, Lina (Institut d'Investigació Biomèdica Sant Pau) ; Kirby, A.M. (Royal Marsden NHS Trust. Institute of Cancer Research) ; Blaes, A.H. (Division of Hematology/Oncology/Transplantation. University of Minnesota) ; Farmakis, D. (University of Cyprus Medical School) ; Curigliano, Giuseppe (IRCCS. European Institute of Oncology) ; Stephens, R. (Patient Advocate) ; Lyon, A.R. (National Heart and Lung Institute. Imperial College London. Cardio-Oncology Service. Royal Brompton Hospital) ; Lopez-Fernandez, T. (Hospital Universitario La Paz. Instituto de Investigación IdiPAZ. Servicio de Cardiología)
Aims To develop quality indicators (QIs) for the evaluation of the prevention and management of cancer therapy-related cardiovascular toxicity. Methods and results We followed the European Society of Cardiology (ESC) methodology for QI development which comprises (i) identifying the key domains of care for the prevention and management of cancer therapy-related cardiovascular toxicity in patients on cancer treatment, (ii) performing a systematic review of the literature to develop candidate QIs, and (iii) selecting of the final set of QIs using a modified Delphi process. [...]
2023 - 10.1093/ehjqcco/qcac070
European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9 Núm. 1 (january 2023) , p. 1-7  
Registre complet - Creative Commons
2.
10 p, 1.1 MB Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter Study / Pérez-Recio, Sandra (Institut d'Investigació Biomèdica de Bellvitge) ; Pallarès, Natàlia (Institut d'Investigació Biomèdica de Bellvitge) ; Grijota-Camino, Maria D. (Institut d'Investigació Biomèdica de Bellvitge) ; Sánchez-Montalvá, Adrián (Hospital Universitari Vall d'Hebron) ; Barcia, Laura (Complejo Hospitalario Universitario de Pontevedra) ; Campos-Gutiérrez, Silvia (Hospital Universitario de Canarias (La Laguna)) ; Pomar, Virginia (Institut d'Investigació Biomèdica Sant Pau) ; Rabuñal-Rey, Ramón (Hospital Universitario Lucus Augusti (Lugo)) ; Balcells, María Elvira (Pontificia Universidad Católica de Chile) ; Gazel, Denzil (Gaziantep Üniversitesi) ; Montiel, Natalia (Hospital Costa del Sol (Marbella)) ; Vicente, Diego (Donostiako Unibertsitate Ospitalea) ; Goić-Barišić, Ivana (Sveučilište u Splitu) ; Schön, Thomas (Linköpings universitat) ; Paues, Jakob (Linköpings universitat) ; Mareković, Ivana (Klinički bolnički centar Zagreb) ; Cacho-Calvo, Juana (Hospital Universitario de Getafe (Madrid)) ; Barac, Aleksandra (Univerzitet u Beogradu) ; Goletti, Delia (Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani-IRCCS) ; García-Gasalla, Mercedes (Institut d'Investigació Sanitària Illes Balears) ; Barcala, José María (Hospital Universitario de Jerez (Jerez de la Frontera)) ; Tórtola Fernández, María Teresa (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Anibarro, Luis (Complejo Hospitalario Universitario de Pontevedra) ; Suárez-Toste, Isabel (Hospital Universitario de Canarias (La Laguna)) ; Moga, Esther (Institut d'Investigació Biomèdica Sant Pau) ; Gude-González, María José (Hospital Universitario Lucus Augusti (Lugo)) ; Naves, Rodrigo (Universidad de Chile) ; Karsligil, Tekin (Gaziantep Üniversitesi) ; Martin-Peñaranda, Tania (Donostiako Unibertsitate Ospitalea) ; Stevanovic, Goran (Univerzitet u Beogradu) ; Trigo, Matilde (Complejo Hospitalario Universitario de Pontevedra) ; Rubio, Verónica (Institut d'Investigació Biomèdica Sant Pau) ; Karaoǧlan, Ilkay (Gaziantep Üniversitesi) ; Bayram, Nazan (Gaziantep Üniversitesi) ; Alcaide, Fernando (Universitat de Barcelona. Departament de Patologia i Terapèutica Experimental) ; Tebé, Cristian (Institut d'Investigació Biomèdica de Bellvitge) ; Santin, Miguel (Universitat de Barcelona. Departament de Ciències Clíniques)
We investigated whether the difference of antigen tube 2 (TB2) minus antigen tube 1 (TB1) (TB22TB1) of the QuantiFERON-TB gold plus test, which has been postulated as a surrogate for the CD81 T-cell response, could be useful in identifying recent tuberculosis (TB) exposure. [...]
2021 - 10.1128/Spectrum.00972-21
Microbiology Spectrum, Vol. 9 Núm. 3 (december 2021) , p. e00972-21  
Registre complet - Creative Commons

Vegeu també: autors amb noms similars
2 Barac, Aleksandra
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem